RSS   Newsletter   Contact   Advertise with us
Post Online Media

Teva appoints Kåre Schultz as CEO

Kåre SchultzSeptember 12, 2017, Jerusalem, Israel - Teva Pharmaceutical Industries, a pharmaceutical company, announced that it has named Kåre Schultz to become the company’s president and chief executive officer.
Mr. Schultz is a seasoned veteran in the healthcare industry with a distinguished, nearly thirty year career in global pharmaceutical and healthcare companies.

Over the course of his career, Mr. Schultz has developed a unique perspective overseeing generic and specialty drug portfolios, while managing complex business operations around the world.

He most recently served as the President and Chief Executive Officer of H. Lundbeck A/S.

Prior to his role as President and CEO of H. Lundbeck A/S, Mr. Shultz served as Chief Operating Officer of Novo Nordisk.

Mr. Schultz serves as the Chairman of the Board of Directors of Royal Unibrew A/S, as a member of the Board of Directors of LEGO A/S and as a member of the Board of Directors of Bitten og Mads Clausens Fond, the holding vehicle for Danfoss A/S.

He holds a master’s degree in Economics from the University of Copenhagen.




POST Online Media does not use cookies to collect information about visitors.   OK, hide this message   Third party ads may be using cookies, you can see how here.